Winston Kung - 16 Aug 2024 Form 4 Insider Report for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Role
Director
Signature
/s/ Meghan Houghton, attorney-in-fact for Winston Kung
Issuer symbol
CRBP
Transactions as of
16 Aug 2024
Net transactions value
$0
Form type
4
Filing time
20 Aug 2024, 16:48:47 UTC
Previous filing
28 Jun 2024
Next filing
14 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRBP Common Stock, par value $0.0001 per share Award $0 +5,566 $0.000000 5,566 16 Aug 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRBP Stock options (right to buy) Award $0 +5,566 $0.000000 5,566 16 Aug 2024 Common Stock 5,566 $53.52 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 16, 2024, 5,566 restricted stock units ("RSUs") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant.
F2 This amount includes 5,566 unvested RSUs that were granted on August 16, 2024 and will vest 100% on the one-year anniversary from the date of grant.
F3 The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant.